Figure 4.

a. The percentages of CD45RA⁺ cells in CD4⁺CD25⁺CD127⁻Foxp3⁺ cells in CD3⁺CD4⁺ cells are shown for Patients 1 to 5. b. The percentages of CD31⁺ cells in CD4⁺CD25⁺CD127⁻Foxp3⁺ cells in CD3⁺CD4⁺ cells are shown for Patients 1 to 5. The inset shows the percentage of CD31⁺ cells in CD4⁺CD25⁺CD127⁻Foxp3⁺ cells from the pretransplant time point until week 2 post-transplant. c. The percentages of Ki-67⁺ cells in CD4⁺CD25⁺CD127⁻Foxp3⁺ cells in CD3⁺CD4⁺ cells are shown for Patients 1 to 5. d. The percentages of HLA-DR⁺ cells in CD4⁺CD25⁺CD127⁻Foxp3⁺ cells in CD3⁺CD4⁺ cells are shown for Patients 1 to 5.